84 related articles for article (PubMed ID: 1626165)
21. Reproducibility of the glucagon test.
Arnold-Larsen S; Madsbad S; Kühl C
Diabet Med; 1987; 4(4):299-303. PubMed ID: 2956039
[TBL] [Abstract][Full Text] [Related]
22. Effects of glucagon on islet beta cell function in patients with diabetes mellitus.
Wang T; Xiao XH; Li WH; Wang H; Sun Q; Yuan T; Yang GH
Chin Med Sci J; 2008 Jun; 23(2):117-20. PubMed ID: 18686632
[TBL] [Abstract][Full Text] [Related]
23. C-peptide response to glucagon in patients with non-insulin-dependent diabetes mellitus.
Juang JH; Huang HS; Huang MJ
J Formos Med Assoc; 1992 May; 91(5):491-6. PubMed ID: 1358326
[TBL] [Abstract][Full Text] [Related]
24. Effect of age on beta-cell response to exogenous glucagon in man.
Giustina A; Cravarezza P; Romanelli G; Spandrio S; Zuccato F
Horm Metab Res; 1989 May; 21(5):277-9. PubMed ID: 2673962
[No Abstract] [Full Text] [Related]
25. Correlations between fasting plasma C-peptide, glucagon-stimulated plasma C-peptide, and urinary C-peptide in insulin-treated diabetics.
Gjessing HJ; Matzen LE; Frøland A; Faber OK
Diabetes Care; 1987; 10(4):487-90. PubMed ID: 3304899
[TBL] [Abstract][Full Text] [Related]
26. A mathematical model for pattern of change in beta-cell reserve and factors affecting residual reserve within the first 2 years of type 1 diabetes.
Altuntas Y
J Endocrinol Invest; 2002 Dec; 25(11):987-92. PubMed ID: 12553560
[TBL] [Abstract][Full Text] [Related]
27. Repeatability of C-peptide response in glucagon stimulation test.
Sarlund H; Siitonen O; Laakso M; Pyörälä K
Acta Endocrinol (Copenh); 1987 Apr; 114(4):515-8. PubMed ID: 3577583
[TBL] [Abstract][Full Text] [Related]
28. [Residual beta-cell function in type diabetes].
Prando R; Melga PL; Accoto S; Buzzo P; Cheli V; De Grandi R; Augeri C; Zanardi A
Minerva Endocrinol; 1988; 13(2):95-102. PubMed ID: 3050429
[No Abstract] [Full Text] [Related]
29. The value of C-peptide level measurements in diabetes mellitus.
Rajasoorya C; Tan YT; Chew LS
Ann Acad Med Singap; 1990 Jul; 19(4):463-6. PubMed ID: 2221804
[TBL] [Abstract][Full Text] [Related]
30. C-peptide used in the estimation of islet beta-cell function in diabetes.
Gjessing HJ
Dan Med Bull; 1992 Oct; 39(5):438-52. PubMed ID: 1424818
[No Abstract] [Full Text] [Related]
31. Discrimination of type I from insulin-treated type II diabetic patients by C-peptide measurement.
Cravarezza P; Radaeli E; Toffoli C; Rigosa C
Acta Diabetol Lat; 1986; 23(4):345-50. PubMed ID: 3564834
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of beta-cell function in diabetic Taiwanese children using a 6-min glucagon test.
Tung YC; Lee JS; Tsai WY; Hsiao PH
Eur J Pediatr; 2008 Jul; 167(7):801-5. PubMed ID: 17874132
[TBL] [Abstract][Full Text] [Related]
33. [Insulin reserve of insulin-dependent diabetics. Role of C-peptide in the hormonal balance in diabetes].
Dauzat J; Moinade S; Gaillard G; Glanddier Y; Gachon AM
Presse Med; 1983 Sep; 12(32):1983-7. PubMed ID: 6225101
[TBL] [Abstract][Full Text] [Related]
34. Increment of C-peptide after glucagon injection determines the progressive nature of Japanese type 2 diabetes: a long-term follow-up study.
Fukui T; Oono K; Hara N; Yamamoto T; Nagashima M; Naito H; Hirano T
Endocr J; 2013; 60(6):715-24. PubMed ID: 23386398
[TBL] [Abstract][Full Text] [Related]
35. A randomized trial of a somatostatin analog for preserving beta cell function in children with insulin dependent diabetes mellitus.
Grunt JA; al-Hakim H; Willoughby L; Howard CP
J Pediatr Endocrinol; 1994; 7(4):331-4. PubMed ID: 7735371
[TBL] [Abstract][Full Text] [Related]
36. Standard breakfast test: an alternative to glucagon testing for C-peptide reserve?
Escobar-Jiménez F; Herrera Pombo JL; Gómez-Villalba R; Nuñez del Carril J; Aguilar M; Rovira A
Horm Metab Res; 1990 Jun; 22(6):339-41. PubMed ID: 2199364
[TBL] [Abstract][Full Text] [Related]
37. C-peptide in diabetic children after stimulation with clucagon compared with fasting C-peptide levels in non-diabetic children.
Ludvigsson J; Heding LG
Acta Endocrinol (Copenh); 1977 Jun; 85(2):364-71. PubMed ID: 577329
[TBL] [Abstract][Full Text] [Related]
38. [C-peptide, diabetogenic factor and the blood anticoagulating system in patients with the insulin-dependent type of diabetes mellitus before and after heparin therapy].
Balabolkin MI; Kudriashov BA; Levitskaia ZI; Liapina LA; Ul'ianov AM
Probl Endokrinol (Mosk); 1990; 36(1):25-8. PubMed ID: 2330356
[TBL] [Abstract][Full Text] [Related]
39. Plasma and urinary C-peptide in the classification of adult diabetics.
Koskinen P; Viikari J; Irjala K; Kaihola HL; Seppälä P
Scand J Clin Lab Invest; 1986 Nov; 46(7):655-63. PubMed ID: 3538365
[TBL] [Abstract][Full Text] [Related]
40. Plasmatic levels of fibronectin in diabetics with and without retinopathy. Correlation with some hormonal and metabolic parameters.
Nardelli GM; Guastamacchia E; Di Paolo S; Lacasella R; Balice A; Montedoro P; Cospite MR; Giorgino R
Acta Diabetol Lat; 1987; 24(3):255-62. PubMed ID: 3318258
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
